Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02118233 · ClinicalTrials.gov registry record

Cognitive Outcome After Carotid Surgery

A clinical trial of Carotid Stenosis, sponsored by Lahey Clinic.

Completed
Registry status
56
Enrollment target
3
Study locations

NCT02118233: Completed study of Carotid Stenosis, sponsored by Lahey Clinic.

NCT02118233 is a study of Carotid Stenosis that has completed, run by Lahey Clinic. The registered enrollment target is 56 participants, below the 595-participant average among 11 other Carotid Stenosis trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02118233, a study of Carotid Stenosis, has completed, sponsored by Lahey Clinic.

COMPLETED
Registry status
56 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to understand how carotid endarterectomy (CEA) or percutaneous carotid angioplasty and stenting (CAS) affect memory and thinking resulting in improving or worsening of thinking or memory. There have been many studies on this subject, some finding that certain patients gain improvement in their brain function and others might get worse. The goal of this study is to discover which patients are more likely to have improved cognitive functioning. Carotid endarterectomy (CEA) and percutaneous carotid angioplasty and stenting (CAS) are not investigational and are an accepted treatment for your condition. In addition, subjects that choose not to undergo surgery will also be included in this study.

Primary Outcome

Quantitative flow MRA studies will be performed pre-operative and postoperative for those undergoing carotid revascularization surgery. Those not undergoing surgery will have this test upon study enrollment and approximately 1 month from study enrollment date.

Conditions Studied

Study Locations (3)

New York

  • University of Buffalo Neurosurgery (UBNS) - Buffalo
  • StonyBrook - Stony Brook

Massachusetts

  • Lahey Clinic, Inc. - Burlington

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2014-04
Est. Completion 2019-11
Lahey Clinic

43 total trials

What the finished NCT02118233 record still lists

NCT02118233 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 595-participant average among 11 other Carotid Stenosis trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Carotid Stenosis appearing as the primary indexed condition, and to 0 interventions.

NCT02118233 reports a single indexed study location in New York, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02118233 about?

NCT02118233 is a clinical study titled "Cognitive Outcome After Carotid Surgery". The purpose of this study is to understand how carotid endarterectomy (CEA) or percutaneous carotid angioplasty and stenting (CAS) affect memory and thinking resulting in improving or worsening of thinking or memory. There have been many studies on this subject, some finding that certain patients ga...

What is the current status of trial NCT02118233?

This trial is currently completed. The enrollment target is 56 participants. The study started on 2014-04. Estimated completion is 2019-11.

What conditions does trial NCT02118233 study?

This clinical trial studies the following conditions: Carotid Stenosis.

Who is sponsoring clinical trial NCT02118233?

This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02118233 being conducted?

This trial has 3 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carotid Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02118233's enrollment target sits among peer trials

56 11th of 11 higher than 1 of 11 other Carotid Stenosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Carotid Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02118233, the US trial registry maintained by the National Library of Medicine. NCT02118233 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.